StepStone Group’s T2 Biosystems, Inc TTOO Stock Holding History

StepStone Group’s Portfolio TTOO Stock Details TTOO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	–	Sell	-2	Closed	-$188K	–	15
2015 Q1	$188K	Buy	+2	New	+$186K	0.05%	12

Other funds holding TTOO

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

PVMCV

Polaris Venture Management Co V Boston, Massachusetts $14.1M AUM 121.41% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

HCS

Harvest Capital Strategies San Francisco, California $73.7M AUM 7.47% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

StepStone Group's TTOO Position: Q2 2015 in Review

StepStone Group sold out of T2 Biosystems, Inc (TTOO) in Q2 2015, closing a stake of 2 shares — an estimated $188K sold.

StepStone Group first reported a position in TTOO in Q1 2015 and held it in 1 quarter. The position peaked at $188K in Q1 2015. 47 funds tracked by Wall St. Rank hold TTOO as of Q2 2015.

StepStone Group reported no remaining T2 Biosystems, Inc position as of Q2 2015 after selling out during the quarter.
StepStone Group sold 2 T2 Biosystems, Inc shares in Q2 2015, an estimated $188K.
StepStone Group first reported a position in T2 Biosystems, Inc in Q1 2015 and held it in 1 quarter.
StepStone Group's T2 Biosystems, Inc position peaked at $188K in Q1 2015.
47 funds tracked by Wall St. Rank held T2 Biosystems, Inc as of Q2 2015.

Based on StepStone Group's 13F filing for Q2 2015, filed 11 Aug 2015.